Literature DB >> 32030065

Proliferating Trichilemmal Cysts: A Clinicopathological Study of 14 Cases.

Pablo Vargas-Mora1, Diego Orlandi1, Claudia Morales2, Irene Araya1.   

Abstract

Entities:  

Year:  2019        PMID: 32030065      PMCID: PMC6984044          DOI: 10.4103/ijt.ijt_112_19

Source DB:  PubMed          Journal:  Int J Trichology        ISSN: 0974-7753


× No keyword cloud information.
Sir, Proliferating trichilemmal (pilar) cysts (PTCs) are a rare dermal neoplasm, usually benign, but with locally invasive and even metastatic potential. First described by Wilson-Jones in 1966, it consists of a scalp lesion with similar pathologic features to squamous cell carcinoma (SCC) in an elderly patient.[12] Subsequently, these tumors were given multiple denominations, such as invasive pilomatrixoma, trichoclamidocarcinoma, subepidermal acanthoma, and giant hair matrix tumor, among others.[2] This makes it difficult to determine its true incidence. They may arise de novo or in a preexisting cystic lesion, and based on few case reports, it is three to four times more common in women, usually seen in elderly patients, and located in up to 85% of cases on the scalp.[123] The objective of this study was to evaluate the clinical and histopathological characteristics of patients with PTC in a group of latin patients. We performed a retrospective, observational study in the Dermatology and Pathology departments of a Chilean university hospital. Using the pathology department database on all skin biopsies with a pathological diagnosis of PTC between 1995 and 2018, the biopsy slides were reviewed again by a dermatopathologist to confirm the diagnoses. Sex, age, clinical diagnosis, location, and histopathological diagnosis were analyzed. A total of 14 patients were included [Table 1]; 9 (64.3%) were female, with an average age of 56 years (±20.9, range: 16–85 years). The clinical diagnoses were nonspecific tumor = 6 (43%), epidermal cyst = 3 (21.4%), trichilemmal cyst = 3 (21.4%), pilomatrixoma = 1 (7.1%), and atypical nevus = 1 (7.1%). The tumors were located on the scalp in 11 cases (78.7%), hand in 1 case (7.1%), elbow in 1 case (7.1%), and thigh in 1 case (7.1%) [Figure 1]. Eleven (78.7%) lesions corresponded to PTC [Figure 2a], 2 (14.2%) to hybrid proliferating cysts with epidermoid and trichilemmal components, the latter being predominant, and 1 (7.1%) to a PTC with moderately differentiated intracystic SCC [Figure 2b and c].
Table 1

Clinical and histopathological characteristics of patients presenting with proliferating trichilemmal cysts

NumberAgeSexClinical diagnosisLocationHistopathological diagnosis
185FemaleNonspecific tumorScalpPTC
247FemaleAtypical nevusScalpPTC
345MaleEpidermal cystScalpPTC
447FemalePilomatrixomaThighPTC
586FemaleNonspecific tumorScalpPTC
645MaleNonspecific tumorScalpPTC
764FemaleNonspecific tumorHandPTC
821FemaleEpidermal cystScalpPTC
976FemaleNonspecific tumorScalpPTC with moderately differentiated intracystic SCC
1067MaleNonspecific tumorElbowPTC
1156MaleEpidermal cystScalpPTC
1216FemaleTrichilemmal cystScalpPTC
1364MaleTrichilemmal cystScalpHybrid proliferating cyst with epidermoid and trichilemmal components
1465FemaleTrichilemmal cystScalpHybrid proliferating cyst with epidermoid and trichilemmal components

PTC – Proliferating trichilemmal cyst; SCC – Squamous cell carcinoma

Figure 1

(a) Proliferating trichilemmal cyst on the scalp (arrow) with multiple trichilemmal cysts. (b) Proliferating trichilemmal cyst in elbow

Figure 2

(a) Cyst with hyperkeratosis and squamous proliferation (H and E, ×20). (b) Proliferating trichilemmal cyst with squamous cell carcinoma (H and E, ×40). (c) Malignant squamous proliferation with marked cellular pleomorphism, hyperchromasia, and mitotic figures (H and E, ×400)

Clinical and histopathological characteristics of patients presenting with proliferating trichilemmal cysts PTC – Proliferating trichilemmal cyst; SCCSquamous cell carcinoma (a) Proliferating trichilemmal cyst on the scalp (arrow) with multiple trichilemmal cysts. (b) Proliferating trichilemmal cyst in elbow (a) Cyst with hyperkeratosis and squamous proliferation (H and E, ×20). (b) Proliferating trichilemmal cyst with squamous cell carcinoma (H and E, ×40). (c) Malignant squamous proliferation with marked cellular pleomorphism, hyperchromasia, and mitotic figures (H and E, ×400) The present study is the first report on this rare entity in Latin patients and showed a younger age of presentation compared to previously reported series, with a female predominance and a higher incidence on the scalp, which correlates with features described on the available medical literature.[13] It also highlights the presence of two proliferating cysts of the trichilemmal–epidermal hybrid type, which, according to the available evidence, there are no reported cases of proliferative epithelial cysts with both components.[4] Consequently, when evaluating these lesions, it is necessary to distinguish if there are areas with a granular layer, which defines the epidermoid component and therefore the diagnosis of hybrid proliferative cysts. Furthermore, we report the case of an intracystic SCC, since the malignant transformation arising within a cutaneous cyst is a very rare but described phenomenon.[35] Further studies with larger sample size, possibly multicenter, and more extensive clinical evaluation will help to better understand the clinical behavior of this pathology, in specific populations.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  5 in total

1.  Trichilemmal Carcinoma from Proliferating Trichilemmal Cyst on the Posterior Neck.

Authors:  Ui Geon Kim; Dong Bee Kook; Tae Hun Kim; Chung Hun Kim
Journal:  Arch Craniofac Surg       Date:  2017-03-25

2.  Spectrum of Hybrid Cysts and Their Clinical Significance.

Authors:  Ray-San Chang; Xiao-Feng Yao; Yu-Hung Wu
Journal:  Am J Dermatopathol       Date:  2018-06       Impact factor: 1.533

Review 3.  Proliferating trichilemmal tumors: a review of the literature.

Authors:  Anita K Satyaprakash; Daniel J Sheehan; Omar P Sangüeza
Journal:  Dermatol Surg       Date:  2007-09       Impact factor: 3.398

4.  Proliferating pilar tumors: a clinicopathologic study of 76 cases with a proposal for definition of benign and malignant variants.

Authors:  Jay Ye; Oscar Nappi; Paul E Swanson; James W Patterson; Mark R Wick
Journal:  Am J Clin Pathol       Date:  2004-10       Impact factor: 2.493

5.  Proliferating trichilemmal tumors: clinicopathologic evaluation is a guide to biologic behavior.

Authors:  Andrew L Folpe; Amy K Reisenauer; Thomas Mentzel; Arno Rütten; Alvin R Solomon
Journal:  J Cutan Pathol       Date:  2003-09       Impact factor: 1.587

  5 in total
  1 in total

1.  TP53 Abnormalities and MMR Preservation in 5 Cases of Proliferating Trichilemmal Tumours.

Authors:  Raquel Martín-Sanz; José María Sayagués; Pilar García-Cano; Mikel Azcue-Mayorga; María Del Carmen Parra-Pérez; María Ángeles Pacios-Pacios; Enric Piqué-Durán; Jorge Feito
Journal:  Dermatopathology (Basel)       Date:  2021-05-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.